Inventor · disambiguated record
Garrit-Jan Boudewijn Van Ommen
Also filed as: VAN OMMEN GARRIT-JAN B · VAN OMMEN GARRIT-JAN BOUDEWIJN
21 granted patents·24 pending applications·616 citations·filing 1997–2022
96Inventor score
Files withACADEMISCH ZIEKENHUIS LEIDEN17BIOMARIN TECH BV11PROSENSA TECHNOLOGIES BV3UNIV LEIDEN3DE KIMPE JOSEPHUS JOHANNES2
Top patents by PatentIndex Score
45 records- 0198US8361979B2Means and method for inducing exon-skippingACADEMISCH ZIEKENHUIS LEIDEN·Filed 2007·Granted Jan 29, 2013·142 cites·7 claims
- 0297USRE48468EMeans and methods for counteracting muscle disordersBIOMARIN TECH BV·Filed 2018·Granted Mar 16, 2021·25 cites·42 claims
- 0397US9926557B2Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNADE KIMPE JOSEPHUS JOHANNES·Filed 2011·Granted Mar 27, 2018·50 cites·11 claims
- 0497US9243245B2Means and methods for counteracting muscle disordersDE KIMPE JOSEPHUS JOHANNES·Filed 2010·Granted Jan 26, 2016·76 cites·22 claims
- 0596US9528109B2Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNAPROSENSA TECH B V·Filed 2014·Granted Dec 27, 2016·60 cites·23 claims
- 0696US7973015B2Induction of exon skipping in eukaryotic cellsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2003·Granted Jul 5, 2011·157 cites·4 claims
- 0794US9139828B2Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansPLATENBURG GERARD JOHANNES·Filed 2010·Granted Sep 22, 2015·41 cites·15 claims
- 0887US10364432B2Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteinsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Jul 30, 2019·7 cites·4 claims
- 0984US9896687B2Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structureVAN OMMEN GARRIT JAN BOUDEWIJN·Filed 2005·Granted Feb 20, 2018·4 cites·1 claims
- 1084US2023151362A1Methods and means for efficient dkipping of exon 45 in duchenne muscular dystrophy pre-mrnaBIOMARIN TECH BV·Filed 2022·Application pending·0 cites
- 1183US8802645B2Molecule for treating an inflammatory disorderVAN OMMEN GARRIT-JAN BOUDEWIJN·Filed 2012·Granted Aug 12, 2014·13 cites·23 claims
- 1281US11427820B2Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNABIOMARIN TECH BV·Filed 2019·Granted Aug 30, 2022·0 cites·10 claims
- 1381US8304398B2Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed geneT HOEN PETER ABRAHAM CHRISTIAAN·Filed 2007·Granted Nov 6, 2012·19 cites·17 claims
- 1478US10113165B2Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Granted Oct 30, 2018·1 cites·13 claims
- 1574US10246707B2Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansBIOMARIN TECH BV·Filed 2015·Granted Apr 2, 2019·1 cites·12 claims
- 1672US9611471B2Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteinsVAN ROON-MOM WILHELMINA M C·Filed 2011·Granted Apr 4, 2017·3 cites·6 claims
- 1772US2019112604A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNABIOMARIN TECH BV·Filed 2018·Application pending·0 cites
- 1872US2019119679A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNABIOMARIN TECH BV·Filed 2018·Application pending·0 cites
- 1972US2019177725A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNABIOMARIN TECH BV·Filed 2019·Application pending·0 cites
- 2070US2020332298A1Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteinsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Application pending·0 cites
- 2170US2021207138A1Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansBIOMARIN TECH BV·Filed 2020·Application pending·0 cites
- 2268US2014221458A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAPROSENSA TECHNOLOGIES BV·Filed 2014·Application pending·0 cites
- 2368US2014357855A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Application pending·0 cites
- 2468US2020224203A1Antisense oligonucleotide directed removal of proteolytic cleavage sites, the hchwa-d mutation, and trinucleotide repeat expansionsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2020·Application pending·0 cites
- 2568US2014113955A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAPROSENSA TECHNOLOGIES BV·Filed 2013·Application pending·0 cites
- 2668US2014128592A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAPROSENSA TECHNOLOGIES BV·Filed 2013·Application pending·0 cites
- 2768US2014357698A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Application pending·0 cites
- 2867US7507800B2Diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determinationUNIV LEIDEN·Filed 2003·Granted Mar 24, 2009·2 cites·7 claims
- 2966US2017107512A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNABIOMARIN TECH BV·Filed 2016·Application pending·0 cites
- 3065US2009228998A1Induction of exon skipping in eukaryotic cellsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2009·Application pending·0 cites
- 3165US2016194636A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 3265US2016168570A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 3365US2016251658A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 3464US2016304864A1Means and methods for counteracting muscle disordersBIOMARIN TECH BV·Filed 2016·Application pending·0 cites
- 3562US2015218559A1Modulation of exon recognition in pre-mrna by interfering with the secondary rna structureACADEMISCH ZIEKENHUIS LEIDEN·Filed 2015·Application pending·0 cites
- 3662US2019292541A1Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansBIOMARIN TECH BV·Filed 2019·Application pending·0 cites
- 3761US10590421B2Antisense oligonucleotide directed removal of proteolytic cleavage sites, the HCHWA-D mutation, and trinucleotide repeat expansionsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Mar 17, 2020·0 cites·7 claims
- 3861US2008209581A1Induction of exon skipping in eukaryotic cellsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2007·Application pending·0 cites
- 3960US2014039037A1Antisense oligonucleotide directed removal of proteolytic cleavage sites, the hchwa-d mutation, and trinucleotide repeat expansionsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2013·Application pending·0 cites
- 4051US2012270930A1Methods and compositions for dysferlin exon-skippingVAN DER MAAREL SILVERE MARIA·Filed 2009·Application pending·0 cites
- 4151US2009312532A1Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secodary rna structureVAN DEUTEKOM JUDITH CHRISTINA·Filed 2006·Application pending·0 cites
- 4245US5928867AMethod of isolating exonic gene segments of eukaryotic genes, exon trapping vectors for use thereinUNIV LEIDEN·Filed 1997·Granted Jul 27, 1999·10 cites·11 claims
- 4340US9353169B2Means and methods for modulating NOTCH3 protein expression and/or the coding region of NOTCH3; compositions and use thereof in the treatment of CADASILACADEMISCH ZIEKENHUIS LEIDEN·Filed 2015·Granted May 31, 2016·0 cites·4 claims
- 4436US6733966B1Diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determinationUNIV LEIDEN·Filed 1998·Granted May 11, 2004·5 cites·10 claims
- 4530US9062311B2Means and methods for modulating NOTCH3 protein expression and/or the coding region of NOTCH3; compositions and use thereof in the treatment of CADASILLESNIK OBERSTEIN SASKIA ANNE-MARIE JENNY·Filed 2010·Granted Jun 23, 2015·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Garrit-Jan Boudewijn Van Ommen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →